Search
MDxHealth SA
MDXHAdd to Watchlist
0.507USD
+0.096+23.48%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
26.04MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+23.48%
5 Days
+7.92%
1 Month
-23.21%
6 Months
-85.80%
Year to Date
-85.80%
1 Year
-76.08%
Key Figures
0.420Open
0.540High
2.22MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
4.33%Turnover Ratio
0.411Prev. Close
0.414Low
820.87KTurnover
LossP/E Static
-1.29P/B
0.00%Div Yield TTM
-19.77%ROA
5.33052wk High
2.06Volume Ratio
-38.07MNet Profit
51.36MShares
-0.6509EPS TTM
0.56Beta
-2440.41%ROE
0.68052wk Low
30.71%Amplitude
56.05%Gross Margin
26.04MMarket Cap
-8.98Reward/Risk
4.00%Risk Rate
TradingKey Stock Score of MDxHealth SA
Currency: USD Updated: 2026-06-30Key Insights
MDxHealth SA's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered undervalued, ranking 130 out of 387 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 2.90.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
MDxHealth SA's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
MDxHealth SA Highlights
StrengthsRisks
MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 53.68% year-on-year.
Overvalued
The company’s latest PE is -0.63, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 25.38M shares, decreasing 1.08% quarter-over-quarter.
Held by Steven Cohen
Star Investor Steven Cohen holds 63.68K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 3.02.
Analyst Rating
Based on
6
analysts
Strong Buy
Current Rating
6.040
Target Price
+325.35%
Upside Space
MDxHealth SA News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
MDxHealth SA Info
MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.
Ticker SymbolMDXH
CompanyMDxHealth SA
CEOMr. Michael K. McGarrity
Websitehttps://mdxhealth.com/
Related Instruments
-0.64%
-0.05%
-2.95%
-0.23%
-2.41%
-1.64%
-0.22%
+1.75%
-0.29%
-0.79%
+0.26%
-2.00%
-2.10%
-2.41%
+1.68%
0.00%
+0.19%
-1.97%
+0.06%
-0.44%Popular Instruments
52283.700
+29.400 (+0.06%)
29935.500
+136.200 (+0.46%)
7493.000
+17.500 (+0.23%)
15216.000
-139.000 (-0.91%)
69509.000
+24.000 (+0.04%)
6291.400
+16.000 (+0.26%)
67.544
-0.424 (-0.62%)
294.380
+5.020 (+1.73%)
197.580
-2.510 (-1.25%)
4053.440
+22.670 (+0.56%)
FAQs
What is the current price of MDxHealth SA (MDXH)?
The current price of MDxHealth SA (MDXH) is 0.51.
What is the symbol of MDxHealth SA?
The ticker symbol of MDxHealth SA is MDXH.
What is the 52-week high of MDxHealth SA?
The 52-week high of MDxHealth SA is 5.33.
What is the 52-week low of MDxHealth SA?
The 52-week low of MDxHealth SA is 0.68.
What is the market capitalization of MDxHealth SA?
The market capitalization of MDxHealth SA is 26.04M.
Is MDxHealth SA (MDXH) currently rated as Buy, Hold, or Sell?
According to analysts, MDxHealth SA (MDXH) has an overall rating of Buy, with a price target of 2.90.
What is the Earnings Per Share (EPS TTM) of MDxHealth SA (MDXH)?
The Earnings Per Share (EPS TTM) of MDxHealth SA (MDXH) is -0.67.